Central venous disease in hemodialysis patients
Kidney Research and Clinical Practice
;
: 309-317, 2019.
Artículo
en Inglés
| WPRIM
| ID: wpr-759010
ABSTRACT
Central venous disease (CVD) is difficult to treat and often resistant to treatment. In CVD, hemodialysis vascular access should sometimes be abandoned, or in serious cases, the patient's life may be threatened. Therefore, prevention is ideal. However, as the prevalence of chronic kidney disease (CKD) has increased steadily with population aging, CKD patients with a peripherally inserted central catheter (PICC) are encountered frequently. PICCs can cause CVD, and the basilic vein, which is regarded as the important last option for native arteriovenous fistula (AVF) creation in end-stage renal disease (ESRD) patients, is destroyed frequently after its use as the entry site of PICC. The most well-established risk factors for CVD are a history of central venous catheter (CVC) insertion and its duration of use. Therefore, to reduce the incidence of CVD, catheterization in the central vein (CV) should be minimized, along with its duration of use. In this review, we will first explain the basic territories of the CV and introduce its pathophysiology, clinical features, and advanced treatment options. Finally, we will emphasize prevention of CVD.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Venas
/
Envejecimiento
/
Cateterismo
/
Incidencia
/
Prevalencia
/
Factores de Riesgo
/
Fístula Arteriovenosa
/
Diálisis Renal
/
Ocimum basilicum
/
Insuficiencia Renal Crónica
Tipo de estudio:
Estudio de etiología
/
Estudio de incidencia
/
Estudio de prevalencia
/
Estudio pronóstico
/
Factores de riesgo
Límite:
Humanos
Idioma:
Inglés
Revista:
Kidney Research and Clinical Practice
Año:
2019
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS